http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#Head
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#assertion
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#provenance
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#pubinfo
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#assertion
http://purl.obolibrary.org/obo/DOID_3908
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_3908
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB09559
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association
http://www.w3.org/2000/01/rdf-schema#label
portrazza tm is an epidermal growth factor receptor egfr antagonist indicated in combination with gemcitabine and cisplatin for first line treatment of patients with metastatic squamous non small cell lung cancer 1 1 limitation of use portrazza is not indicated for treatment of non squamous non small cell lung cancer 1 2 5 6 14 2 portrazza tm is indicated in combination with gemcitabine and cisplatin for first line treatment of patients with metastatic squamous non small cell lung cancer portrazza is not indicated for treatment of non squamous non small cell lung cancer see warnings and precautions 5 6 14 2
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB09559
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#provenance
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#pubinfo
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#sig
http://purl.org/nanopub/x/hasSignature
JQ3ur+2NrejCz4bLGmSGWxqqKT0y5vUUFvLIRmq8+kKGN7G67AG1JFNBzi8Tk4DpVcQJ4VbuaxY4dZR75Ir8I9HqKTSGB831XYcrRNuuwD17SVa/DXVYx3zp+A4CF449OpkxLiusyIRz3VMy2HB7dH6dVZDo86mkWsNbE1qhBNc=
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c
http://purl.org/dc/terms/created
2021-06-12T12:49:14.696+02:00
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs